Health
Researchers develop synthetic defective SARS-CoV-2 genome that inhibits viral replication – News-Medical.Net
A shorter genome comprising only a part of the SARS-CoV-2’s RNA genome competes with the normal virus for growth and can potentially prevent viral replication.
A shorter genome comprising only a part of the SARS-CoV-2’s RNA genome competes with the normal virus for growth and can potentially prevent viral replication.
The devastating impact of the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to significant efforts to curb its transmission. When RNA viruses, like the SARS-CoV-2, replicate there could be versions of the virus that have large deletions in the viral genome,…
-
Noosa News19 hours agoMan killed, woman seriously injured in collision in Wongabel, Atherton Tablelands, Queensland
-
Noosa News18 hours agoMoreton Bay oyster farm survives cyclone with help of wave wall innovation
-
Noosa News20 hours agoHelicopter pilots saving lives, providing food and fodder in flooded outback Queensland
-
Noosa News23 hours ago’Lethal new opioids’ prompt Wide Bay pill testing call